What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?

Background Neurologic deterioration (ND) occurs in one-third of patients with stroke. However, the true incidence of ND and risk for adverse outcomes remains unknown because no standardized definition of ND exists. Our study compared the prognostic value of a range of definitions for ND in patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of stroke and cerebrovascular diseases 2013-07, Vol.22 (5), p.675-682
Hauptverfasser: Siegler, James E., BS, Boehme, Amelia K., MSPH, Kumar, Andre D., BS, Gillette, Michael A., MSPH, Albright, Karen C., DO, MPH, Martin-Schild, Sheryl, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 682
container_issue 5
container_start_page 675
container_title Journal of stroke and cerebrovascular diseases
container_volume 22
creator Siegler, James E., BS
Boehme, Amelia K., MSPH
Kumar, Andre D., BS
Gillette, Michael A., MSPH
Albright, Karen C., DO, MPH
Martin-Schild, Sheryl, MD, PhD
description Background Neurologic deterioration (ND) occurs in one-third of patients with stroke. However, the true incidence of ND and risk for adverse outcomes remains unknown because no standardized definition of ND exists. Our study compared the prognostic value of a range of definitions for ND in patients with acute ischemic stroke (AIS). Methods All patients who presented to our center with AIS within 48 hours of symptom onset between July 2008 and June 2010 were retrospectively identified. Patient demographics, National Institutes of Health Stroke Scale (NIHSS) scores, etiologies of ND, and outcome measures were compared between patients according to a range of ND definitions using receiver operating characteristic analyses. Results Three hundred forty-seven patients were included. The 2 definitions of ND with the highest sensitivity and specificity for several outcome measures were tested against each other: an increase in the NIHSS score by ≥2 or ≥4 points in a 24-hour period. More than one third (36.9%) of patients experienced ≥2-point ND versus 17.3% with ≥4-point ND. Patients who experienced ND by either definition had prolonged hospitalization ( P < .001), poorer functional outcome (discharge modified Rankin Scale score >2; P < .001), and higher discharge NIHSS score ( P < .001) compared to patients without ND. Compared to patients without ND, a ≥2-point ND was associated with a 3-fold risk of death (odds ratio 3.120; 95% confidence interval 1.231-7.905; P < .0165) after adjusting for admission NIHSS score, serum glucose, and age. Conclusions A ≥2-point ND is a sensitive indicator of poor outcome and in-hospital mortality. An accepted definition of ND is needed to systematically study and compare results across trials for ND in patients with stroke.
doi_str_mv 10.1016/j.jstrokecerebrovasdis.2012.04.012
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5535077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1052305712001127</els_id><sourcerecordid>S1052305712001127</sourcerecordid><originalsourceid>FETCH-LOGICAL-c574t-87adaaae1e6b0d759522f27af4a2831fc35828dfddc949c2d6c813b2780c44cb3</originalsourceid><addsrcrecordid>eNqVkk1v1DAQhi1ERUvhLyCfkRJsJ15nL0Vl-ehKq_awII6WY082TrN2ZTsr9cJvx-lCBYhLLx7LM_PMyO-L0FtKSkro4t1QDjEFfwsaArTBH1Q0NpaMUFaSuszhGTqjvGJFwyl9nu-Es6IiXJyilzEOhFDKG_4CnTImmFgydoZ-fO9VwqteuR1g63DqAV-rZL1TI167mGyaEkTsO3wFakw93j6sgLdajfns_TQa_BE663IjTMGPfmd1fkkQrA8PqBl8qTMHr6PuYZ_zR8r7V-ikU2OE17_iOfr2-dPX1VWxufmyXl1uCs1FnYpGKKOUAgqLlhjBl5yxjgnV1Yo1Fe10xRvWmM4YvayXmpmFbmjVMtEQXde6rc7RxZF7N7V7MBpcCmqUd8HuVbiXXln5d8bZXu78QXJecSJEBnw4AnTwMQboHnspkbM6cpD_U0fO6khSyxwy5M2fWzwifsuRCzbHAsh_cbAQZNQWnAZjA-gkjbdPm3fxD06P1tms3C3cQxz8FLLMUVIZc4_czn6Z7ULZbBUmqp_BQcfX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Siegler, James E., BS ; Boehme, Amelia K., MSPH ; Kumar, Andre D., BS ; Gillette, Michael A., MSPH ; Albright, Karen C., DO, MPH ; Martin-Schild, Sheryl, MD, PhD</creator><creatorcontrib>Siegler, James E., BS ; Boehme, Amelia K., MSPH ; Kumar, Andre D., BS ; Gillette, Michael A., MSPH ; Albright, Karen C., DO, MPH ; Martin-Schild, Sheryl, MD, PhD</creatorcontrib><description>Background Neurologic deterioration (ND) occurs in one-third of patients with stroke. However, the true incidence of ND and risk for adverse outcomes remains unknown because no standardized definition of ND exists. Our study compared the prognostic value of a range of definitions for ND in patients with acute ischemic stroke (AIS). Methods All patients who presented to our center with AIS within 48 hours of symptom onset between July 2008 and June 2010 were retrospectively identified. Patient demographics, National Institutes of Health Stroke Scale (NIHSS) scores, etiologies of ND, and outcome measures were compared between patients according to a range of ND definitions using receiver operating characteristic analyses. Results Three hundred forty-seven patients were included. The 2 definitions of ND with the highest sensitivity and specificity for several outcome measures were tested against each other: an increase in the NIHSS score by ≥2 or ≥4 points in a 24-hour period. More than one third (36.9%) of patients experienced ≥2-point ND versus 17.3% with ≥4-point ND. Patients who experienced ND by either definition had prolonged hospitalization ( P &lt; .001), poorer functional outcome (discharge modified Rankin Scale score &gt;2; P &lt; .001), and higher discharge NIHSS score ( P &lt; .001) compared to patients without ND. Compared to patients without ND, a ≥2-point ND was associated with a 3-fold risk of death (odds ratio 3.120; 95% confidence interval 1.231-7.905; P &lt; .0165) after adjusting for admission NIHSS score, serum glucose, and age. Conclusions A ≥2-point ND is a sensitive indicator of poor outcome and in-hospital mortality. An accepted definition of ND is needed to systematically study and compare results across trials for ND in patients with stroke.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2012.04.012</identifier><identifier>PMID: 22727922</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acute stroke ; Age Factors ; Aged ; Area Under Curve ; Biomarkers - blood ; Blood Glucose - analysis ; Brain Ischemia - blood ; Brain Ischemia - diagnosis ; Brain Ischemia - mortality ; Brain Ischemia - physiopathology ; Cardiovascular ; Chi-Square Distribution ; definition ; deterioration ; Disability Evaluation ; Disease Progression ; Female ; Hospital Mortality ; Hospitalization ; Humans ; Length of Stay ; Logistic Models ; Male ; Middle Aged ; National Institutes of Health Stroke Scale ; Nervous System - physiopathology ; Neurology ; Odds Ratio ; Patient Discharge ; Predictive Value of Tests ; prognosis ; Retrospective Studies ; Risk Factors ; ROC Curve ; Severity of Illness Index ; Stroke - blood ; Stroke - diagnosis ; Stroke - mortality ; Stroke - physiopathology ; Terminology as Topic ; Time Factors</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2013-07, Vol.22 (5), p.675-682</ispartof><rights>National Stroke Association</rights><rights>2013 National Stroke Association</rights><rights>Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c574t-87adaaae1e6b0d759522f27af4a2831fc35828dfddc949c2d6c813b2780c44cb3</citedby><cites>FETCH-LOGICAL-c574t-87adaaae1e6b0d759522f27af4a2831fc35828dfddc949c2d6c813b2780c44cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1052305712001127$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22727922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Siegler, James E., BS</creatorcontrib><creatorcontrib>Boehme, Amelia K., MSPH</creatorcontrib><creatorcontrib>Kumar, Andre D., BS</creatorcontrib><creatorcontrib>Gillette, Michael A., MSPH</creatorcontrib><creatorcontrib>Albright, Karen C., DO, MPH</creatorcontrib><creatorcontrib>Martin-Schild, Sheryl, MD, PhD</creatorcontrib><title>What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>Background Neurologic deterioration (ND) occurs in one-third of patients with stroke. However, the true incidence of ND and risk for adverse outcomes remains unknown because no standardized definition of ND exists. Our study compared the prognostic value of a range of definitions for ND in patients with acute ischemic stroke (AIS). Methods All patients who presented to our center with AIS within 48 hours of symptom onset between July 2008 and June 2010 were retrospectively identified. Patient demographics, National Institutes of Health Stroke Scale (NIHSS) scores, etiologies of ND, and outcome measures were compared between patients according to a range of ND definitions using receiver operating characteristic analyses. Results Three hundred forty-seven patients were included. The 2 definitions of ND with the highest sensitivity and specificity for several outcome measures were tested against each other: an increase in the NIHSS score by ≥2 or ≥4 points in a 24-hour period. More than one third (36.9%) of patients experienced ≥2-point ND versus 17.3% with ≥4-point ND. Patients who experienced ND by either definition had prolonged hospitalization ( P &lt; .001), poorer functional outcome (discharge modified Rankin Scale score &gt;2; P &lt; .001), and higher discharge NIHSS score ( P &lt; .001) compared to patients without ND. Compared to patients without ND, a ≥2-point ND was associated with a 3-fold risk of death (odds ratio 3.120; 95% confidence interval 1.231-7.905; P &lt; .0165) after adjusting for admission NIHSS score, serum glucose, and age. Conclusions A ≥2-point ND is a sensitive indicator of poor outcome and in-hospital mortality. An accepted definition of ND is needed to systematically study and compare results across trials for ND in patients with stroke.</description><subject>Acute stroke</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Area Under Curve</subject><subject>Biomarkers - blood</subject><subject>Blood Glucose - analysis</subject><subject>Brain Ischemia - blood</subject><subject>Brain Ischemia - diagnosis</subject><subject>Brain Ischemia - mortality</subject><subject>Brain Ischemia - physiopathology</subject><subject>Cardiovascular</subject><subject>Chi-Square Distribution</subject><subject>definition</subject><subject>deterioration</subject><subject>Disability Evaluation</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Hospital Mortality</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Length of Stay</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>National Institutes of Health Stroke Scale</subject><subject>Nervous System - physiopathology</subject><subject>Neurology</subject><subject>Odds Ratio</subject><subject>Patient Discharge</subject><subject>Predictive Value of Tests</subject><subject>prognosis</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>ROC Curve</subject><subject>Severity of Illness Index</subject><subject>Stroke - blood</subject><subject>Stroke - diagnosis</subject><subject>Stroke - mortality</subject><subject>Stroke - physiopathology</subject><subject>Terminology as Topic</subject><subject>Time Factors</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkk1v1DAQhi1ERUvhLyCfkRJsJ15nL0Vl-ehKq_awII6WY082TrN2ZTsr9cJvx-lCBYhLLx7LM_PMyO-L0FtKSkro4t1QDjEFfwsaArTBH1Q0NpaMUFaSuszhGTqjvGJFwyl9nu-Es6IiXJyilzEOhFDKG_4CnTImmFgydoZ-fO9VwqteuR1g63DqAV-rZL1TI167mGyaEkTsO3wFakw93j6sgLdajfns_TQa_BE663IjTMGPfmd1fkkQrA8PqBl8qTMHr6PuYZ_zR8r7V-ikU2OE17_iOfr2-dPX1VWxufmyXl1uCs1FnYpGKKOUAgqLlhjBl5yxjgnV1Yo1Fe10xRvWmM4YvayXmpmFbmjVMtEQXde6rc7RxZF7N7V7MBpcCmqUd8HuVbiXXln5d8bZXu78QXJecSJEBnw4AnTwMQboHnspkbM6cpD_U0fO6khSyxwy5M2fWzwifsuRCzbHAsh_cbAQZNQWnAZjA-gkjbdPm3fxD06P1tms3C3cQxz8FLLMUVIZc4_czn6Z7ULZbBUmqp_BQcfX</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Siegler, James E., BS</creator><creator>Boehme, Amelia K., MSPH</creator><creator>Kumar, Andre D., BS</creator><creator>Gillette, Michael A., MSPH</creator><creator>Albright, Karen C., DO, MPH</creator><creator>Martin-Schild, Sheryl, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20130701</creationdate><title>What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?</title><author>Siegler, James E., BS ; Boehme, Amelia K., MSPH ; Kumar, Andre D., BS ; Gillette, Michael A., MSPH ; Albright, Karen C., DO, MPH ; Martin-Schild, Sheryl, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c574t-87adaaae1e6b0d759522f27af4a2831fc35828dfddc949c2d6c813b2780c44cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acute stroke</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Area Under Curve</topic><topic>Biomarkers - blood</topic><topic>Blood Glucose - analysis</topic><topic>Brain Ischemia - blood</topic><topic>Brain Ischemia - diagnosis</topic><topic>Brain Ischemia - mortality</topic><topic>Brain Ischemia - physiopathology</topic><topic>Cardiovascular</topic><topic>Chi-Square Distribution</topic><topic>definition</topic><topic>deterioration</topic><topic>Disability Evaluation</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Hospital Mortality</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Length of Stay</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>National Institutes of Health Stroke Scale</topic><topic>Nervous System - physiopathology</topic><topic>Neurology</topic><topic>Odds Ratio</topic><topic>Patient Discharge</topic><topic>Predictive Value of Tests</topic><topic>prognosis</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>ROC Curve</topic><topic>Severity of Illness Index</topic><topic>Stroke - blood</topic><topic>Stroke - diagnosis</topic><topic>Stroke - mortality</topic><topic>Stroke - physiopathology</topic><topic>Terminology as Topic</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Siegler, James E., BS</creatorcontrib><creatorcontrib>Boehme, Amelia K., MSPH</creatorcontrib><creatorcontrib>Kumar, Andre D., BS</creatorcontrib><creatorcontrib>Gillette, Michael A., MSPH</creatorcontrib><creatorcontrib>Albright, Karen C., DO, MPH</creatorcontrib><creatorcontrib>Martin-Schild, Sheryl, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Siegler, James E., BS</au><au>Boehme, Amelia K., MSPH</au><au>Kumar, Andre D., BS</au><au>Gillette, Michael A., MSPH</au><au>Albright, Karen C., DO, MPH</au><au>Martin-Schild, Sheryl, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>22</volume><issue>5</issue><spage>675</spage><epage>682</epage><pages>675-682</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>Background Neurologic deterioration (ND) occurs in one-third of patients with stroke. However, the true incidence of ND and risk for adverse outcomes remains unknown because no standardized definition of ND exists. Our study compared the prognostic value of a range of definitions for ND in patients with acute ischemic stroke (AIS). Methods All patients who presented to our center with AIS within 48 hours of symptom onset between July 2008 and June 2010 were retrospectively identified. Patient demographics, National Institutes of Health Stroke Scale (NIHSS) scores, etiologies of ND, and outcome measures were compared between patients according to a range of ND definitions using receiver operating characteristic analyses. Results Three hundred forty-seven patients were included. The 2 definitions of ND with the highest sensitivity and specificity for several outcome measures were tested against each other: an increase in the NIHSS score by ≥2 or ≥4 points in a 24-hour period. More than one third (36.9%) of patients experienced ≥2-point ND versus 17.3% with ≥4-point ND. Patients who experienced ND by either definition had prolonged hospitalization ( P &lt; .001), poorer functional outcome (discharge modified Rankin Scale score &gt;2; P &lt; .001), and higher discharge NIHSS score ( P &lt; .001) compared to patients without ND. Compared to patients without ND, a ≥2-point ND was associated with a 3-fold risk of death (odds ratio 3.120; 95% confidence interval 1.231-7.905; P &lt; .0165) after adjusting for admission NIHSS score, serum glucose, and age. Conclusions A ≥2-point ND is a sensitive indicator of poor outcome and in-hospital mortality. An accepted definition of ND is needed to systematically study and compare results across trials for ND in patients with stroke.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22727922</pmid><doi>10.1016/j.jstrokecerebrovasdis.2012.04.012</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1052-3057
ispartof Journal of stroke and cerebrovascular diseases, 2013-07, Vol.22 (5), p.675-682
issn 1052-3057
1532-8511
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5535077
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute stroke
Age Factors
Aged
Area Under Curve
Biomarkers - blood
Blood Glucose - analysis
Brain Ischemia - blood
Brain Ischemia - diagnosis
Brain Ischemia - mortality
Brain Ischemia - physiopathology
Cardiovascular
Chi-Square Distribution
definition
deterioration
Disability Evaluation
Disease Progression
Female
Hospital Mortality
Hospitalization
Humans
Length of Stay
Logistic Models
Male
Middle Aged
National Institutes of Health Stroke Scale
Nervous System - physiopathology
Neurology
Odds Ratio
Patient Discharge
Predictive Value of Tests
prognosis
Retrospective Studies
Risk Factors
ROC Curve
Severity of Illness Index
Stroke - blood
Stroke - diagnosis
Stroke - mortality
Stroke - physiopathology
Terminology as Topic
Time Factors
title What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T13%3A13%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20Change%20in%20the%20National%20Institutes%20of%20Health%20Stroke%20Scale%20Should%20Define%20Neurologic%20Deterioration%20in%20Acute%20Ischemic%20Stroke?&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Siegler,%20James%20E.,%20BS&rft.date=2013-07-01&rft.volume=22&rft.issue=5&rft.spage=675&rft.epage=682&rft.pages=675-682&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2012.04.012&rft_dat=%3Celsevier_pubme%3ES1052305712001127%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22727922&rft_els_id=S1052305712001127&rfr_iscdi=true